Geneva Advisors, LLC - ACCENTIA BIOPHARMACEUTICALS ownership

ACCENTIA BIOPHARMACEUTICALS's ticker is ABPI and the CUSIP is 00430L103. A total of 3 filers reported holding ACCENTIA BIOPHARMACEUTICALS in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Geneva Advisors, LLC ownership history of ACCENTIA BIOPHARMACEUTICALS
ValueSharesWeighting
Q2 2016$010,9250.0%0.00%
Q1 2016$010,9250.0%0.00%
Q4 2015$010,9250.00%
Other shareholders
ACCENTIA BIOPHARMACEUTICALS shareholders Q1 2016
NameSharesValueWeighting ↓
CENTRAL TRUST Co 7,375$00.00%
Geneva Advisors, LLC 10,925$00.00%
BLAIR WILLIAM & CO/IL 17,500$00.00%
View complete list of ACCENTIA BIOPHARMACEUTICALS shareholders